| (210) | Number of the EPO application | 17829499 |
| (220) | Filing date of the EPO application | 2017.12.20 |
| (80) | EPO patent specification publication (B) | EPB nr. 15/2022, 2022.04.13 |
| (110) | EPO patent number | 3559011 |
| (21) | Number of the application | e 2019 1229 |
| (71) | Name(s) of applicant(s), code of the country | MERCK SHARP & DOHME LLC, US;
Idenix Pharmaceuticals LLC, US; |
| (72) | Name(s) of inventor(s), code of the country | RAHEEM Izzat, US;
PAPARIN Jean-Laurent, FR;
RAHALI Houcine, FR;
DA COSTA Daniel, FR;
DUKHAN David, FR; |
| (73) | Name(s) of owner(s), code of the country | MERCK SHARP & DOHME LLC, US;
Idenix Pharmaceuticals LLC, US; |
| (54) | Title of the invention | ANTIVIRAL ESTER PRODRUGS OF TENOFOVIR |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07F 9/6561 (2006.01.01); A61K 31/675 (2006.01.01); A61P 31/18 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2019.12.31 |
| (30) | Priority | 201662437753 P, 2016.12.22, US; 201762574493 P, 2017.10.19, US |
| (86) | International application | PCT/US2017/067470, 2017.12.20 |
| (87) | International publication | WO 2018/119013, 2018.06.28 |